Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Aftab
Aftab Jasir, Lund SE
| Patent application number | Description | Published |
|---|---|---|
| 20080255055 | Use of Derivatives of Dipeptides for the Manufacture of of a Medicament for the Treamtent of Microbial Infections - The invention relates to compositions comprising a compound based on the general formula (I) R | 10-16-2008 |
| 20090118198 | NOVEL PEPTIDE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS FOR TREATING WOUNDS - The invention relates to a compound having the general formula (I) R | 05-07-2009 |
| 20100247648 | ANTIMICROBIAL COMPOUNDS - The invention relates to compositions comprising a compound based on the general formula (I) | 09-30-2010 |
Aftab Keval, Hayward, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110123985 | COLUMN ENRICHMENT OF PCR BEADS COMPRISING TETHERED AMPLICONS - An enrichment module and method are provided for enriching a population of templated beads and separating them from non-templated beads. The method can include hybridizing a templated bead with an enrichment bead to form a complex, trapping the complex in a filtration medium, washing non-templated beads through the filtration medium while retaining the complex, and then eluting the templated bead from the complex. The module can include a column for enrichment and filtration material exhibiting desired size-exclusion properties. | 05-26-2011 |
Aftab Kherani, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090088482 | Compositions and Methods For Treating Heart Failure - The present invention provides compositions and methods for the following: preventing and treating heart failure; preventing heart failure in a patient with a pre-heart failure condition; treating and preventing heart failure with ischemic and non-ischemic causes; treating and preventing heart failure in a subject status post myocardial infarction; reversing damage to the heart following myocardial infarction; by administering to a subject an effective amount of an adrenergic beta-agonist either alone or in combination with an effective amount of an adrenergic beta-1 antagonist. FIG. | 04-02-2009 |